Menu

Top Stories

Published on Thursday, April 11, 2019

Moderated discussion: “Advancing the innovation ecosystem: Working together for patients,” in Washington, DC

Moderated discussion: “Advancing the innovation ecosystem: Working together for patients,” in Washington, DC

On April 3, 2019, Francis Collins, MD, PhD, director of the National Institutes of Health (NIH), Mikael Dolsten, MD, PhD, chief scientific officer and president, Worldwide Research, Development and Medical, Pfizer, joined in a discussion led by Susan Dentzer, visiting fellow at the Robert J. Margolis Center for Health Policy, Duke University, in Washington DC.

Photo: Francis Collins, MD, PhD, director of the NIH (left) and author Alejandro Hernandez, editorial manager of the Alpha-1 Foundation (right)

For 60 minutes, Collins, Dolsten, and Dentzer engaged in a conversation with the theme of: “Advancing the innovation ecosystem: working together for patients,” where they emphasized the need for continued collaboration between the private and public sectors, along with the patient community, in order to advance new and emerging technologies and innovative approaches for potentially life-saving treatments and new outcomes in medicine.

“We are currently living in remarkable times with amazing things happening in areas such as cancer immuno-therapy, gene therapy, and gene editing. The things that are happening right now, I had no idea they would even be possible just five or six years ago,” expressed Collins when asked about the current position “the ecosystem,” as they described the collaboration between the private and public sectors with small biotech companies; an ecosystem with symbiotic characteristics where all contributors play an important role in a tremendous team effort, in medical research.

Collins and Dolsten agreed on the importance of advocacy groups and organizations as well as the patient community, in being part of the process for better outcomes and the ability to bring new and potential treatments for various conditions to the clinic, including rare diseases, such as Alpha-1 Antitrypsin Deficiency (Alpha-1). 

“We need you, the patient community, you are the reason we have gotten this far,” said Collins.

“One of the most important resources needed for this ecosystem to strive is you, the patient. We need to line-up our resources and keep the ecosystem going, including the patient community. There is no one better to bring together what others (physicians) can do than patients: you inspire all of us,” expressed Dolsten.

The Alpha-1 Foundation applauds and supports these types of initiatives, in which patients become partners and are of vital importance for therapeutic development. 

The panel also mentioned that it is critical to spread awareness and education in the medical community, and being able to have early diagnosis and detection, while mentioning the Accelerating Medicines Partnership (AMP), a public-private partnership between the NIH, the U.S. Food and Drug Administration (FDA), multiple biopharmaceutical, and life science companies, as well as non-profit organizations to transform the current model for developing new diagnostics and treatments by jointly identifying and validating promising biological targets for therapeutics.

The ultimate goal of AMP is to increase the number of new diagnostics and therapies for patients and reduce the time and cost of developing them.

“Patient participation is critical for AMP, especially to remind us what we are doing and why-and-who we are doing it for,” said Collins, who also mentioned the Foundation for the National Institutes of Health (FNIH) as being instrumental in bringing together funds and resources from both the private and public sectors, to work in mutual collaboration in research projects that will ultimately benefit the patient community.

The Alpha-1 Foundation applauds these types of initiatives that support research and bring innovative approaches to the table for the benefit of the patient community, as we are committed to finding a cure for Alpha-1 and improving the lives of Alphas, and those affected by the condition, worldwide.

For more information, please visit the Collaboration Ecosystem website and the AMP website.


Print

Gratitude and good wishes this holiday season to you, the foundation of our success

Tuesday, December 23, 2014
Because the goodwill of those we serve is the foundation of our success, it’s a pleasure at this holiday time to say thank you. We wish you a happy holiday season and a New Year of health, happiness and prosperity. Board...
Divider

FDA to lift lifetime ban on gay blood donors

Tuesday, December 23, 2014
The Food and Drug Administration announced on Tuesday that it would scrap a decades-old lifetime prohibition on blood donation by gay and bisexual men, a change that experts said was long overdue and could lift the annual blood supply by as much...
Divider

Foundation joins coalition urging House to support drug benefits

Monday, December 22, 2014
The Alpha-1 Foundation and COPD Foundation joined two dozen other organizations of the Medicare Access of Patients Rx (MAPRx) Coalition in writing to leaders of the U.S. House Committee on Energy and Commerce, urging support of Part D drug...
Divider

Alpha-1 Canada launches kids’ program with ‘Look At Us'

Monday, December 22, 2014
Just in time for the holidays, Alpha-1 Canada is launching its A-1 Kids Program to bring information, education and support to children with Alpha-1, their caregivers, family members and healthcare providers. Early intervention and education...
Divider

Happy Holidays from the Alpha-1 Foundation

Friday, December 19, 2014
Because the goodwill of those we serve is the foundation of our success, it’s a pleasure at this holiday time to say thank you. We wish you a happy holiday season and a New Year of health, happiness and prosperity. Board &...
Divider

Alpha Daryl Kunz draws strength from community, cycling

Friday, December 19, 2014
What if your passion preserved your life? Would you think about it differently, even to the point of making it a priority? For Daryl Kunz, whose passion for 20 years has been cycling, these questions are more than rhetorical musings. Every...
Divider

Alpha Daryl Kunz draws strength from community, cycling

Friday, December 19, 2014
What if your passion preserved your life? Would you think about it differently, even to the point of making it a priority? For Daryl Kunz, whose passion for 20 years has been cycling, these questions are more than rhetorical musings. Every...
Divider

Alpha-1 Foundation CEO John Walsh elected to NHC Board

Thursday, December 18, 2014
John Walsh, president and co-founder of the Alpha-1 Foundation, has been re-elected to the National Health Council‘s 2015 Board of Directors. Walsh served on the Board this year, and as NHC Board Chair in 2005-06. Read more about him...
Divider

‘Allergy & Asthma Today’ features article on Alpha-1

Wednesday, December 17, 2014
The Winter 2014 issue of Allergy & Asthma Today, the Allergy and Asthma Network (AANMA)'s quarterly magazine, features the article "How Alpha-1 Mimics Asthma and COPD," by Alpha-1 Foundation Communications Director Bob Campbell. He interviews...
Divider

National Health Council launches upgraded site to help with health insurance choices

Wednesday, December 17, 2014
The National Health Council has launched its newly upgraded website, PuttingPatientsFirst.net. The website gives people the tools to gain a better understanding of their options in the health insurance marketplace and find...
Divider

Study: E-cigarette use has overtaken smoking among youths

Wednesday, December 17, 2014
A new federal survey has found that electronic cigarette use among teenagers has surpassed the use of traditional cigarettes as smoking has continued to decline. Health advocates say the trend for e-cigarette use, or vaping, is dangerous because...
Divider

FDA OKs system that aims to make blood plasma donation safer, but experts have reservations

Wednesday, December 17, 2014
The Food and Drug Administration on Tuesday approved the first system that could be used by blood banks to destroy viruses and bacteria in donated blood plasma, potentially making transfusions safer. The system represents an extra safety step...
Divider
First54555657585960616263Last

Article Search

Enter keywords in text box and click Search button for results.

Archive